FDA Approved: BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM — Supplemental Application (Alvogen Inc.)

View source ↗

Summary

FDA approved a supplemental application for Alvogen's buprenorphine/naloxone sublingual film, enabling the generic product to be marketed for opioid use disorde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Buprenorphine and naloxone sublingual film (Buprenorphine and naloxone)

Snippet

SUPPL AP for BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM (BUPRENORPHINE AND NALOXONE)